Work

Phase 1 study of selinexor plus mitoxantrone, etoposide, and cytarabine in acute myeloid leukemia.

Year: 2018

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2018.36.15_suppl.7048

Authors: Bhavana Bhatnagar, Alison R. Walker, Alice S. Mims, Sumithira Vasu, Rebecca B. Klisovic, Gregory Behbehani, James Stewart Blachly, Karilyn T.M. Larkin, Meixiao Long, Qiuhong Zhao, Parvathi Ranganathan, John C. Byrd, William G. Blum, Ramiro Garzon

Institutions: The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, The Ohio State University, The Ohio State University Wexner Medical Center, Winship Cancer Institute

Language: English

Topic: Acute Myeloid Leukemia Research

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2889641989

Cites:

Cited by: 8

Related to: 10